PEDIATRICS Vol. 81 No. 3 March 1988, pp. 471-472
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MILSTIEN, J. B.
Right arrow Articles by KURITSKY, J. N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by MILSTIEN, J. B.
Right arrow Articles by KURITSKY, J. N.

Informed Consent

JULIE B. MILSTIEN PhD1, THOMAS P. GROSS MD, MPH1, and JOEL N. KURITSKY MD1

1 Office of Epidemiology and Biostatistics FDA, Rockville, MD

In Reply.—

Dr Cook's letter raises serious concerns about the medical-legal implications of the use of the term "adverse reaction reports" to describe reports of temporally associated events suspected of being caused by a drug or vaccine exposure. We have chosen to use this term because, in most cases, the reporter has not merely seen an event following an exposure but has some level of suspicion that it might be linked to the exposure.